Blood Cancer Journal (Mar 2024)
Correction: GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
- Paula Rodriguez-Otero,
- Niels W. C. J. van de Donk,
- Kodandaram Pillarisetti,
- Ingrid Cornax,
- Deeksha Vishwamitra,
- Kathleen Gray,
- Brandi Hilder,
- Jaszianne Tolbert,
- Thomas Renaud,
- Tara Masterson,
- Christoph Heuck,
- Colleen Kane,
- Raluca Verona,
- Philippe Moreau,
- Nizar Bahlis,
- Ajai Chari
Affiliations
- Paula Rodriguez-Otero
- Clínica Universidad de Navarra, CCUN, University of Navarra
- Niels W. C. J. van de Donk
- Amsterdam University Medical Center, Vrije Universiteit Amsterdam
- Kodandaram Pillarisetti
- Janssen Research & Development
- Ingrid Cornax
- Janssen Research & Development
- Deeksha Vishwamitra
- Janssen Research & Development
- Kathleen Gray
- Janssen Scientific Affairs
- Brandi Hilder
- Janssen Research & Development
- Jaszianne Tolbert
- Janssen Research & Development
- Thomas Renaud
- Janssen Research & Development
- Tara Masterson
- Janssen Research & Development
- Christoph Heuck
- Janssen Research & Development
- Colleen Kane
- Janssen Research & Development
- Raluca Verona
- Janssen Research & Development
- Philippe Moreau
- University Hospital Hôtel-Dieu
- Nizar Bahlis
- Arnie Charbonneau Cancer Research Institute, University of Calgary
- Ajai Chari
- Icahn School of Medicine at Mount Sinai
- DOI
- https://doi.org/10.1038/s41408-024-01018-6
- Journal volume & issue
-
Vol. 14,
no. 1
pp. 1 – 1
Abstract
No abstracts available.